Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab : part 3 of the open-label, multicenter, phase 1b PAVO study
Nahi, Hareth (Karolinska Institute. Department of Medicine)
Usmani, Saad Z. (Memorial Sloan Kettering Cancer Center)
Mateos, M. V (Hospital Universitario de Salamanca)
van de Donk, Niels W C J (Department of Hematology. Vrije Universiteit Amsterdam)
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Plesner, Torben (Vejle Hospital and University of Southern Denmark)
Bandyopadhyay, Nibedita (Janssen Research & Development. LLC)
Hellemans, Peter (Janssen Research & Development)
Tromp, Brenda (Janssen Research & Development. LLC)
Nnane, Ivo (Janssen Research & Development. LLC)
Zemlickis, Donna (Janssen Research & Development. LLC)
Chari, Ajai (Icahn School of Medicine at Mount Sinai)
Moreau, Philippe (University Hospital Hôtel-Dieu (Nantes, França))
DOI: 10.1080/10428194.2022.2148221
The record appears in these collections:
Research literature >
UAB research groups literature >
Research Centres and Groups (research output) >
Health sciences and biosciences >
Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) >
Josep Carreras Leukaemia Research Institute Articles >
Research articlesArticles >
Published articles
Record created 2024-03-07, last modified 2024-05-04